Alliance for Patient Access

08/28/2026

When roadblocks in the system impact patients, clinicians can choose to speak up. AfPA is proud to elevate clinician voices in the fight for a more connected, patient-centered health care system.

Learn more at allianceforpatientaccess.org

08/27/2026

Respiratory conditions affect every part of life. Thanks to new treatment options, asthma patients are able to live life fully.

Learn more: https://bit.ly/45Yf4GT

08/25/2026

Patients with hepatitis C deserve care that treats the whole patient.

Learn more: https://bit.ly/3WDj36F

08/24/2026

As many as one in 250 people have hypertrophic cardiomyopathy. Patient access to innovative treatments can help reduce the risk of hospitalization, minimize symptoms and improve health outcomes.

Learn more: https://bit.ly/3SCz8KR

08/21/2026

Millions of Americans rely on medications to treat their condition, however, they must be approved by the FDA first. FDA user fee programs allow for a more efficient drug review process, leading to increased access to necessary medications.

Learn more: https://bit.ly/3TVPH4T

08/20/2026

Corticosteroids are essential treatments, but cumulative exposure can carry risks. A new report from the Corticosteroid Stewardship Alliance explores how stewardship can improve patient safety.

Learn more:

The Corticosteroid Stewardship Alliance has released a new white paper, Advancing Safer, More Accountable Use of Corticosteroids, calling for a coordinated approach to improve patient safety while preserving access to one of medicine's most widely used treatments. The white paper, based on insights....

08/18/2026

FDA approval is an important milestone, but it does not guarantee access. As new therapies emerge, coverage policies must evolve too.

Medical innovation is giving patients more options for how their conditions are treated. Recent FDA approvals span cardiovascular disease, Alzheimer’s disease and thyroid eye disease, with advances that include a first-of-its-kind oral therapy and a new way to receive an existing treatment. These ...

08/17/2026

Medicare's Bridge Program expanded GLP-1 access for eligible seniors as of July 1.

Eligible Medicare beneficiaries finally have a path to access to FDA-approved GLP-1 medications to treat obesity. Beginning July 1, a pilot Bridge program began offering 18 months of Medicare coverage, dramatically reducing the barriers that have kept many seniors from accessing the increasingly pop...

08/11/2026

When health plans force medication changes, heart patients pay the price.

Cardiovascular disease remains a leading cause of death in the United States. But patients who rely on specialty medications to keep their heart conditions under control now routinely see their care interrupted by insurance requirements. One common practice is known as non-medical switching.

08/11/2026

Patients need personalized care, not prescription drug affordability boards. PDABs encourage a one-size-fits-all approach which diminishes quality of care.

Learn more: https://bit.ly/3RK7bQJ